川芎Chuanxiong Rhizoma是著名的川产道地药材,为"血中之气药",其药用历史悠久,具有重要的临床价值。但重金属镉超标、精深加工不足、产业链条不健全等瓶颈问题,制约了川芎产业的健康发展。基于川芎产业发展现状,概述了川芎资源、生产关键技术、化学成分、质量控制、药理与临床、新药研发与大健康产品、专利申请等研究进展,从全产业链分析探讨川芎产业发展中存在的问题,并提出相应的发展策略与方法,为川芎产业的高质量发展提供科学支撑。

Chuanxiong (Chuanxiong Rhizoma) is one of the famous authentic medicinal herb produced in Sichuan. As a blood activating and analgesic drug, it has a long history of clinical application and has important clinical value, known as "Qi medicine in blood". Due to the excessive heavy metal cadmium, insufficient deep-processing, incomplete industrial chain and other bottleneck issues, the development of Chuanxiong Rhizoma industry has been restricted. Based on the development status of Chuanxiong Rhizoma industry, focusing on the current status of research progress on Chuanxiong Rhizoma, including resources, key production technologies, chemical composition, quality control, pharmacology and clinical application, new drug research and development, and big health products, patent application and so on. And the challenges encountered in Chuanxiong Rhizoma in the process of industrial development are analyzed, and corresponding development strategies and methods are put forward to provide scientific support for high-quality development of Chuanxiong Rhizoma industry.

“四川省科技计划资助”项目（2023NSFSC1994）